Table 3 Antimicrobial susceptibility of EAEC isolates from asymptomatic humans in southern Vietnam
Antimicrobial | No. of antimicrobial resistant EAEC (%) | |||
|---|---|---|---|---|
Chicken farmer | Rural individual | Urban individual | Total | |
(N = 16) | (N = 16) | (N = 2) | (N = 34) | |
Tetracycline | 8 (50.0) | 14 (87.5) | 2 (100) | 24 (70.6) |
Trimethoprim/sulfamethoxazole | 13 (81.2) | 14 (87.5) | 2 (100) | 29 (85.3) |
Chloramphenicol | 11 (68.8) | 2 (12.5) | 0 | 13 (38.2) |
Gentamicin | 13 (81.2) | 11 (68.8) | 0 | 24 (70.6) |
Amikacin | 0 | 1 (6.2) | 0 | 1 (2.9) |
Ciprofloxacin | 0 | 9 (56.2) | 0 | 9 (26.5) |
Ampicillin | 16 (100) | 16 (100) | 2 (100) | 34 (100) |
Amoxicillin/clavulanic acid | 8 (50.0) | 7 (43.8) | 2 (100) | 17 (50.0) |
Ceftazidime | 6 (37.5) | 11 (68.8) | 0 | 17 (50.0) |
Ceftriaxone | 8 (50.0) | 14 (87.5) | 0 | 22 (64.7) |
Third-generation cephalosporins | 8 (50.0) | 14 (87.5) | 0 | 22 (64.7) |
ESBL-producing | 6 (37.5) | 11 (68.8) | 0 | 17 (50.0) |
Meropenem | 0 | 0 | 0 | 0 |
MDR | 13 (81.2) | 15 (93.8) | 2 (100) | 30 (88.2) |